Queen’s University Belfast:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Queen's University Belfast - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9373
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Queen’s University Belfast (Queen’s University) is an educational institution that offers education and research services. The institute provides undergraduate, professional development and postgraduate programs. Its postgraduate programs comprise postgraduate diploma in nursing, MSc advanced professional and clinical practice, master of philosophy, doctor of philosophy, a postgraduate certificate in non-medical prescribing and doctorate in nursing practice, among others. Queen’s University operates Institutes For Global Food Security, Institutes For Global Peace, Institutes For Security and Justice, Institutes For Electronics, Institutes For Health Sciences, Institutes For Communications and Information Technology, and others. The institute has operations in the UK and Ireland. Queen’s University is headquartered in Belfast, the UK.

Queen’s University Belfast – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Queen’s University Belfast, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Queen’s University Belfast, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Queen’s University Belfast, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Queen’s University Belfast, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Queen’s University Belfast, Medical Devices Deals, 2012 to YTD 2018 9
Queen’s University Belfast, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Queen’s University Belfast, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Queen’s University Belfast Enters into Agreement with Fusion Antibodies 11
CV6 Therapeutics Enters into Partnership with Queen’s University Belfast 12
Almac Discovery Enters Into Agreement With Queen’s University Belfast For Drug Discovery 13
Equity Offering 15
Re-Vana Therapeutics Spin Off from Queen’s University Belfast 15
Causeway Sensors Spin Off from Queens University Belfast 16
Queen’s University Belfast – Key Competitors 17
Queen’s University Belfast – Key Employees 18
Queen’s University Belfast – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Government and Public Interest 20
Sep 06, 2018: Queen’s University researchers discover ground-breaking process which destroys bowel cancer 20
Feb 15, 2018: Queen’s University announces novel drug delivery system with potential to reduce rates of HIV 21
Feb 14, 2018: Belfast scientist awarded £250,000 for heart failure research 22
Oct 26, 2017: £800K Boost for Queen’s University Researchers to Improve Bowel Cancer Treatment 23
May 30, 2017: Queen’s Researchers Make Breakthrough Discovery in Fight Against Bowel Cancer 25
Mar 24, 2017: Study shows potential of stem cell therapy to repair lung damage 27
Product News 28
Feb 09, 2017: International team of researchers develop new model for earlier treatments for AMD 28
Feb 01, 2017: Researchers develop best-yet cell culture system for age-related macular degeneration 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Queen's University Belfast, Pharmaceuticals & Healthcare, Key Facts 2
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Queen's University Belfast, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Queen's University Belfast, Deals By Therapy Area, 2012 to YTD 2018 8
Queen's University Belfast, Medical Devices Deals, 2012 to YTD 2018 9
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Queen's University Belfast Enters into Agreement with Fusion Antibodies 11
CV6 Therapeutics Enters into Partnership with Queen's University Belfast 12
Almac Discovery Enters Into Agreement With Queen’s University Belfast For Drug Discovery 13
Re-Vana Therapeutics Spin Off from Queen’s University Belfast 15
Causeway Sensors Spin Off from Queens University Belfast 16
Queen's University Belfast, Key Competitors 17
Queen's University Belfast, Key Employees 18

List of Figures
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Queen's University Belfast, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Queen’s University Belfast:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aegean Marine Petroleum Network Inc (ANW):石油・ガス:M&Aディール及び事業提携情報
    Summary Aegean Marine Petroleum Network Inc (AMPL) is a provider of marine fuel logistics services. The company markets and offers refined marine fuels and lubricants to ships. Its lubricants include marine fuels, mineral, cargo trading, marine lubricants, synthetic and next generation bio degradabl …
  • Public Financial Holdings Limited (626):企業の財務・戦略的SWOT分析
    Public Financial Holdings Limited (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Utah Medical Products Inc (UTMD):企業の財務・戦略的SWOT分析
    Summary Utah Medical Products Inc (Utah Medical) is a medical device company that offers disposable and reusable products. The company offers blood pressure monitoring and blood management, gynecology, urology and electrosurgery, perinatology, respiratory and OEM products. Its blood pressure monitor …
  • Samsung Heavy Industries Co Ltd:戦略・SWOT・企業財務分析
    Samsung Heavy Industries Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Samsung Heavy Industries Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Knight-Swift Transportation Holdings Inc. (KNX):企業の財務・戦略的SWOT分析
    Knight-Swift Transportation Holdings Inc. (KNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • BioChain Institute Inc-医療機器分野:企業M&A・提携分析
    Summary BioChain Institute Inc (BioChain) is a medical device company that designs, develops and markets diagnostic products. The company provides processed bio-sample products and analysis services used in translational medicine, companion diagnostics, and clinical product research and development. …
  • Compagnie Financiere Richemont SA:戦略・SWOT・企業財務分析
    Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report Summary Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Genesis Energy, L.P.:企業の戦略・SWOT・財務情報
    Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report Summary Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Maritz Holdings Inc.:企業の戦略的SWOT分析
    Maritz Holdings Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Chenguang Biotech Group Co Ltd (300138):企業の財務・戦略的SWOT分析
    Chenguang Biotech Group Co Ltd (300138) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Envipco Holding NV (ENVI):企業の財務・戦略的SWOT分析
    Envipco Holding NV (ENVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Windflow Technology Limited (WTL):企業の財務・戦略的SWOT分析
    Windflow Technology Limited (WTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Biotronik SE & Co KG:企業の戦略的SWOT分析
    Biotronik SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • ICA Gruppen AB:企業の戦略・SWOT・財務情報
    ICA Gruppen AB - Strategy, SWOT and Corporate Finance Report Summary ICA Gruppen AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Hyatt Hotels Corporation:企業のM&A・事業提携・投資動向
    Hyatt Hotels Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hyatt Hotels Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • ENN Energy Holdings Ltd (2688):企業の財務・戦略的SWOT分析
    ENN Energy Holdings Ltd (2688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Alterna Savings and Credit Union Limited:企業の戦略・SWOT・財務情報
    Alterna Savings and Credit Union Limited - Strategy, SWOT and Corporate Finance Report Summary Alterna Savings and Credit Union Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Societatea Nationala Nuclearelectrica SA (SNN):企業の財務・戦略的SWOT分析
    Societatea Nationala Nuclearelectrica SA (SNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • OncoSec Medical Inc (ONCS):企業の財務・戦略的SWOT分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company. The company offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor t …
  • Eesti Energia AS:企業の戦略・SWOT・財務情報
    Eesti Energia AS - Strategy, SWOT and Corporate Finance Report Summary Eesti Energia AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆